New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
12:46 EDTMRK, JNJ, UNH, HPQ, CAT, ZIP, CAR, SKUL, LNKDOn The Fly: Midday Wrap
Stocks on Wall Street were significantly higher at midday after U.S. lawmakers agreed on a deal to avoid some of the tax hikes associated with the fiscal cliff, but many of the issues remaining were simply pushed off by the last-second agreement. The stop-gap measure puts off the drastic spending cuts that were due to take effect, but it did not eliminate them, and it failed to raise the debt limit, meaning another political showdown is coming. The day’s economic data points went largely unnoticed as most investors breathed a sigh of relief and sent the averages soaring right at the opening bell... ECONOMIC EVENTS: In the U.S., Markit's final reading for December's purchasing managers' index came in at 54.0, which was up from 52.8 a month ago and beat expectations for a downward revision to 53.6. The ISM's December manufacturing PMI had a reading of 50.7, versus the expected 50.5, while the prices paid index came in at 55.5, versus the expected 50.8. A separate report showed construction spending fell 0.3% in November, versus an expected increase of 0.6%. In Europe, Markit's zone-wide PMI edged down to 46.1 in December, compared with its 46.3 preliminary reading and down from 46.2 in November... COMPANY NEWS: Every member of the Dow Jones Industrial Average was higher at midday, with only Merck (MRK), Johnson & Johnson (JNJ) and UnitedHealth (UNH) logging gains of less than 1%. Shares of Hewlett-Packard (HPQ) and Caterpillar (CAT) paced the blue chip index, as each rose over 4%... Reflecting a trend similar to the one seen on the Dow, every S&P sector except for Healthcare was significantly higher... MAJOR MOVERS: Among the notable gainers was Zipcar (ZIP), which rose 48% following its agreement to be acquired for $12.25 per share in cash by Avis Budget (CAR), which also had its shares rise nearly 5%. Among the noteworthy losers were Skullcandy (SKUL), down 14% after Jefferies downgraded the stock to Underperform from Buy, and LinkedIn (LNKD) which fell almost 4% after being downgraded to Equal Weight at Barclays... INDICES: Near 12:30 pm ET, the Dow was up 224.78, or 1.72%, to 13,328.92; the Nasdaq was up 67.24, or 2.23%, to 3,086.75; and the S&P 500 was up 24.81, or 1.74%, to 1,451.00.
News For MRK;JNJ;UNH;HPQ;CAT;ZIP;CAR;SKUL;LNKD From The Last 14 Days
Check below for free stories on MRK;JNJ;UNH;HPQ;CAT;ZIP;CAR;SKUL;LNKD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 18, 2014
07:41 EDTHPQHP upgraded to Buy from Neutral at Monness Crespi
07:39 EDTHPQHP remains a top pick ahead of Q3 results at Deutsche Bank
Subscribe for More Information
August 15, 2014
08:06 EDTSKULSkullcandy, ASTRO Gaming announces patent issuance
Subscribe for More Information
August 14, 2014
15:24 EDTHPQHewlett-Packard volatility increases into Q3 and outlook
Subscribe for More Information
14:13 EDTUNHOmega Advisors gives quarterly update on stakes
Subscribe for More Information
07:25 EDTLNKDCLSA to hold meetings
Silicon Valley Meetings consisting of meeting with various companies in the Silicon Valley area will be held on August 14-15.
06:09 EDTHPQGoogle, HP in talks to collaborate on 'virtual assistant,' The Information says
Subscribe for More Information
05:47 EDTLNKDLinkedIn Sales Navigator could be $4.3B opportunity, says Piper Jaffray
Subscribe for More Information
August 13, 2014
18:02 EDTMRKMerck provides statement on role of PNEUMOVAX 23 in updated ACIP recommendations
Subscribe for More Information
16:52 EDTMRKMerck confirms FDA approval of BELSOMRA
Subscribe for More Information
15:30 EDTMRKFDA approves Belsomra sleep drug
The Food and Drug Administration approved Belsomra tablets for use as needed to treat difficulty in falling and staying asleep. Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information. Belsomra is a controlled substance because it can be abused or lead to dependence. Belsomra is made by Merck, Sharpe & Dohme.
07:55 EDTHPQHP free cash flow upside thesis intact, says Brean Capital
Subscribe for More Information
06:35 EDTLNKDLinkedIn aims for new business valued at $1B, Business Insider says
Subscribe for More Information
06:34 EDTLNKDLinkedIn coverage resumed with a Buy at Stifel
Subscribe for More Information
August 12, 2014
10:31 EDTHPQEx-Autonomy CFO accuses HP of agreement cover-up, Re/code says
Subscribe for More Information
10:06 EDTSKULSkullcandy gaps up following upgrade
Subscribe for More Information
10:00 EDTSKULOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTJNJActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
05:32 EDTSKULSkullcandy upgraded to Hold from Underperform at Jefferies
Subscribe for More Information
August 11, 2014
15:24 EDTHPQBloomberg to hold a summit
Silicon Valley 2014 Cybersecurity Summit to be held in Palo Alto, California on August 12.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use